دورية
Efficacy and Safety of E7777 (improved purity Denileukin diftitox [ONTAK]) in Patients with Relapsed or Refractory Cutaneous T-Cell Lymphoma: Results from Pivotal Study 302
| العنوان: | Efficacy and Safety of E7777 (improved purity Denileukin diftitox [ONTAK]) in Patients with Relapsed or Refractory Cutaneous T-Cell Lymphoma: Results from Pivotal Study 302 |
|---|---|
| المؤلفون: | Foss, Francine M., Kim, Youn H., Prince, H. Miles Miles, Kuzel, Timothy M., Yannakou, Costas K., Ooi, Chean Eng, Xing, Dongyuan, Sauter, Nicholas, Singh, Preeti, Czuczman, Myron, Duvic, Madeleine |
| المصدر: | Blood; November 2022, Vol. 140 Issue: Supplement 1 p1491-1492, 2p |
| قاعدة البيانات: | Supplemental Index |
Full Text Finder | تدمد: | 00064971 15280020 |
|---|---|
| DOI: | 10.1182/blood-2022-166916 |